Skye Bioscience, Inc. Gain (Loss) on Disposition of Business
Skye Bioscience, Inc. (SKYE) reported Gain (Loss) on Disposition of Business of $178.20 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfBusiness · last filed 2026-08-14
- Skye Bioscience, Inc. gain (loss) on disposition of business for the quarter ending 2026-06-30 was $178.20K, a 99.41% increase year-over-year.
- Skye Bioscience, Inc. gain (loss) on disposition of business for the quarter ending 2025-12-31 was $179.99K, a 28.16% increase year-over-year.
- Skye Bioscience, Inc. gain (loss) on disposition of business for the quarter ending 2025-09-30 was $91.40K, a 25.49% increase year-over-year.
- Skye Bioscience, Inc. gain (loss) on disposition of business for the quarter ending 2025-06-30 was $89.36K.
- Skye Bioscience, Inc. gain (loss) on disposition of business for fiscal 2025 was $360.75K, a 73.44% decline from fiscal 2024.
- Skye Bioscience, Inc. gain (loss) on disposition of business for fiscal 2024 was $1.36M.
- Skye Bioscience, Inc. gain (loss) on disposition of business for fiscal 2023 was -$307.09K.
- Skye Bioscience, Inc. gain (loss) on disposition of business for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Disposition of Business 3 month | Gain (Loss) on Disposition of Business 6 month | Gain (Loss) on Disposition of Business 9 month | Gain (Loss) on Disposition of Business 12 month |
|---|---|---|---|---|
| 2026-06-30 | $178.20K 10-Q · filed 2026-08-14 | $178.20K 10-Q · filed 2026-08-14 | ||
| 2025-12-31 | $179.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $271.39K derived: sum of 2 quarters · filed 2026-03-10 | $360.75K derived: sum of 3 quarters · filed 2026-08-14 | $360.75K 10-K · filed 2026-03-10 |
| 2025-09-30 | $91.40K 10-Q · filed 2025-11-10 | $180.76K derived: sum of 2 quarters · filed 2026-08-14 | $180.76K 10-Q · filed 2025-11-10 | $321.20K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $89.36K 10-Q · filed 2026-08-14 | $89.36K 10-Q · filed 2026-08-14 | $229.80K derived: sum of 3 quarters · filed 2026-08-14 | $302.63K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $140.43K derived: sum of 2 quarters · filed 2026-03-10 | $213.27K derived: sum of 3 quarters · filed 2026-03-10 | $213.27K derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-12-31 | $140.43K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $213.27K derived: sum of 2 quarters · filed 2026-03-10 | $213.27K derived: sum of 3 quarters · filed 2026-03-10 | $1.36M 10-K · filed 2026-03-10 |
| 2024-09-30 | $72.84K 10-Q · filed 2025-11-10 | $72.84K derived: sum of 2 quarters · filed 2025-11-10 | $1.22M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $1.15M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $1.15M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$307.09K 10-K · filed 2025-03-20 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |